Starting or Strengthening a Drug Bulletin - A Practical Manual
(2005; 165 pages) View the PDF document
Table of Contents
View the documentPreface
View the documentHow the manual was produced
View the documentAbout ISDB
View the documentExecutive summary
Open this folder and view contents1. Introduction
Open this folder and view contents2. Rational use of medicines
Open this folder and view contents3. What are drug bulletins?
Open this folder and view contents4. Defining aims, target and type of bulletin
Open this folder and view contents5. Planning resources
Open this folder and view contents6. Planning bulletin production: schedules and timing
Open this folder and view contents7. The editorial process
Open this folder and view contents8. Reviewing a new drug: is it a therapeutic advance?
Open this folder and view contentsAnnexe to Chapter 8: Evaluating harm
Open this folder and view contents9. Design and production
Open this folder and view contents10. Dissemination
Close this folder11. Organizational and legal issues
View the document11.1 Introduction
View the document11.2 Why does a drug bulletin need a structure?
Close this folder11.3 Different kind of structures
View the document11.3.1 An association
View the document11.3.2 A foundation
View the document11.3.3 Other legal entities
View the document11.3.4 A bulletin within another organization
View the document11.4 How to deal with legal action
Open this folder and view contents11.5 Copyright
View the document11.6 Further reading
Open this folder and view contents12. Evaluating quality and usefulness
Open this folder and view contents13. Partnership and collaboration
Open this folder and view contents14. Keeping records and creating a memory
Open this folder and view contentsAppendix: Electronic sources of information

11.3 Different kind of structures

The choice of structure partly depends on what the main activities of the organization will be, on how those involved with the bulletin want to regulate decision-making, and on national laws and regulations. Many ISDB drug bulletins have chosen a structure that expresses their non-profit status, such as a foundation or association. Being a non-profit organization does not necessarily mean that the bulletin makes no profits. It means that any profits made by the organization go back towards fulfilling its aims and are not paid out to members or shareholders. As discussed above, a foundation or association may be incorporated, but this is not a requirement in many countries.

to previous section
to next section
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: December 6, 2017